Key result
The provided abstract is truncated and does not report quantitative results for thermocoagulation in the treatment of pregnancy with an acardiac twin.
Why the study?
Does thermocoagulation improve outcomes in twin pregnancies with an acardiac twin?
Does thermocoagulation improve outcomes in twin pregnancies with an acardiac twin?
Thermocoagulation is discussed as an early treatment for twin pregnancies with an acardiac twin, a condition with high perinatal mortality for the pump twin.
Truncated abstract yields no quantitative results; leaves open thermocoagulation efficacy in acardiac twin pregnancies.
In twin pregnancy with acardia, which occurs in about 1 in 35,000 deliveries, the heart and usually other organs fail to develop in one twin.1 The acardiac (“recipient”) twin receives blood from the normal (“pump”) twin, and the blood is then returned to the normal twin.2 The natural history is variable, and some pregnancies proceed to term. Commonly, the acardiac twin becomes grossly edematous, and its size may exceed that of the pump twin. Hydramnios may occur in either sac. The perinatal mortality rate for pump twins is around 55 percent, with death due mainly to congestive cardiac failure or . . .
No takes yet. Share an insight, caveat, or question.
Rodeck et al. (1998) studied Twin pregnancy with an acardiac twin. Thermocoagulation was evaluated. The provided abstract is truncated and does not report quantitative results for thermocoagulation in the treatment of pregnancy with an acardiac twin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: